In this CE activity, expert clinicians will assess recent evidence regarding the use of multimodal imaging and biomarkers that aid in detecting and monitoring UME. They will also evaluate recent clinical data about the use of emerging and approved novel corticosteroid delivery systems in the treatment of UME.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/retinacme/miscellaneous-macular-diseases/20240531/uveitic-macular-edema-therapy-and-optimal-outcomes/overview
- Start Date: 2024-05-31 05:00:00
- End Date: 2024-05-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Bausch + Lomb - Amount: 53070.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest